Jerusalem Pharmaceuticals Company Description
Jerusalem Pharmaceuticals Co. Ltd., together with its subsidiaries, manufactures and sells a range of human medicines and medical supplies in Palestine, the Middle East, North Africa, and internationally.
It operates through two segments: Pharmaceutical Sales and All Other Segments. The company offers over the counter, prescription pharmaceutical, and nutritional supplement products in various dosage forms, including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, and ointments, as well as ear and nose drops and solutions.
It also provides medical devices; detergents; cosmetic; personal hygiene; veterinary; and agricultural products, as well as engages in printing services.
The company’s products are used in cardiovascular, gastrointestinal and metabolic, respiratory, analgesic and musculoskeletal, dermatology, central nervous system, anti-infective, and oncology therapeutic areas.
It operates in Jordan, Algeria, the Kingdom of Saudi Arabia, the United Arab Emirates, Lebanon, Iraq, Qatar, Kuwait, Bahrain, Oman, Yemen, Sudan, Ethiopia, Ivory Coast, Libya, Belarus, and other countries.
The company was founded in 1969 and is headquartered in Ramallah, Palestinian Authority.
| Country | Palestinian Authority |
| Founded | 1969 |
| Industry | Pharmaceutical Preparations |
| Employees | 595 |
| CEO | Mohammed Mahmoud Masrouji |
Contact Details
Address: Nablus Street Ramallah Palestinian Authority | |
| Phone | 970 2 2406550 |
| Website | jepharm.ps |
Stock Details
| Ticker Symbol | JPH |
| Exchange | Palestine Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Mohammed Mahmoud Masrouji | Chief Executive Officer |